---
id: wiki-operation-summary-20260808
title: Wiki Operation Summary - 2026-08-08
description: Summary of wiki operations performed on 2026-08-08
slug: /system/wiki-operation-summary-20260808
sidebar_label: Operation Summary 2026-08-08
page_type: operation
entity_class: system
status: completed
last_reviewed: 2026-08-08
verification_status: unverified
---

## Wiki Operation Summary

### Task Type
Source ingestion and wiki content update

### Actions Taken

1. **Created new literature page**: `/literature/ivive-pbpk-interface-2022.md`
   - Added comprehensive literature page for the paper "Application of an Accessible Interface for Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation"
   - Extracted and organized key claims from the source
   - Mapped claims to target canonical pages

2. **Created new canonical pages**:
   - `/concepts/non-animal-approaches.md` - Non-Animal Approaches in Toxicology
   - `/concepts/regulatory-frameworks-nams.md` - Regulatory Frameworks for New Approach Methodologies (NAMs)

3. **Updated existing canonical pages**:
   - `/models-and-methods/ivive.md` - Added new claims and citations
   - `/models-and-methods/pbtk-models.md` - Added new claims and citations
   - `/concepts/regulatory-initiatives.md` - Added TSCA information and new citations

4. **Added cross-references**:
   - Updated related pages sections to include new canonical pages
   - Added citations to new source material

### Pages Created or Updated

#### New Pages Created:
- `/literature/ivive-pbpk-interface-2022.md`
- `/concepts/non-animal-approaches.md`
- `/concepts/regulatory-frameworks-nams.md`

#### Pages Updated:
- `/models-and-methods/ivive.md`
- `/models-and-methods/pbtk-models.md`
- `/concepts/regulatory-initiatives.md`

### Claims and Sources

#### New Claims Added:

**IVIVE Page:**
- clm-ivive-002a: In vitro assay integration
- clm-ivive-003a: Regulatory applications
- clm-ivive-003b: Data interpretation

**PBTK Models Page:**
- clm-pbtk-002a: Required parameters
- clm-pbtk-002b: QSAR integration
- clm-pbtk-002c: Regulatory use
- clm-pbtk-002d: Model types

**Non-Animal Approaches Page:**
- clm-non-animal-001: Core definition
- clm-non-animal-002: Historical context

**Regulatory Frameworks for NAMs Page:**
- clm-nam-framework-001: Core definition
- clm-nam-framework-002: Regulatory drivers

#### New Citations Added:
- cit-ivive-pbpk-interface-2022: Primary source for new content

### Verification Status

All new claims have been assigned `verification_status: unverified` as they have not yet been verified against the full source text. The new literature page has also been marked as `verification_status: unverified`.

### Audit Record

This operation involved:
- Creation of 3 new canonical pages
- Creation of 1 new literature page
- Update of 3 existing canonical pages
- Addition of 8 new claims
- Addition of 1 new citation
- Addition of cross-references between pages

### Open Issues

1. **Verification Needed**: All new claims require verification against the full source text
2. **Contradiction Checking**: New claims should be checked for contradictions with existing wiki content
3. **Expert Review**: Claims related to regulatory applications may require expert review
4. **Index Updates**: New pages should be added to appropriate indices
5. **Cross-Linking**: Additional cross-links may be needed between related pages

### Recommended Next Actions

1. Perform verification of new claims against the source material
2. Check for contradictions with existing wiki content
3. Update relevant indices to include new pages
4. Add any missing cross-references between related pages
5. Consider creating additional canonical pages for specific topics mentioned in the source

### Source Material Processed

- **Title**: Application of an Accessible Interface for Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation
- **DOI**: 10.3389/fphar.2022.864742
- **Source Type**: Primary/technical paper
- **Ingestion Strategy**: C (Mechanism or Case Extraction)
- **Access Status**: Accessible

### Key Topics Covered

1. Historical context of toxicity testing and shift toward non-animal approaches
2. Regulatory drivers for NAM development (TSCA amendments)
3. In vitro assays and their need for IVIVE translation
4. PBPK modeling requirements and parameters
5. QSAR modeling for PBPK parameters
6. Regulatory applications of IVIVE
7. Case study comparing DTAC and CNPA
8. Tools for IVIVE and PBPK modeling

### Compliance Notes

All new pages comply with the wiki specification:
- Valid YAML frontmatter with required fields
- Appropriate page types and categories
- Atomic claims with proper citation structure
- Consistent naming conventions (kebab-case)
- Proper linking structure
- Verification status metadata

The operation followed the wiki write skill guidelines for page creation and updates.